Acumen Hypotension Prediction Index (HPI) Feature Software vs Ligence Heart

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Acumen Hypotension Prediction Index (HPI) Feature Software

by Edwards Lifesciences

Ligence Heart

by Ligence

AI Verdict

Tool A focuses on real-time predictive monitoring of hypotensive events to aid proactive hemodynamic management in acute care settings. In contrast, Tool B automates the analysis and reporting of echocardiography images, enhancing diagnostic efficiency for cardiologists. While both are cardiology AI tools, they serve distinct purposes within different clinical workflows.

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if your clinical setting requires proactive, real-time prediction and management of hemodynamic instability, particularly to prevent hypotensive events in critical care, emergency, or surgical environments. This tool is ideal for clinicians who need early alerts (up to 15 minutes) to intervene promptly and improve patient outcomes by reducing the incidence and severity of hypotension.

View Acumen Hypotension Prediction Index (HPI) Feature Software →

Choose Ligence Heart if…

Choose Ligence Heart if your cardiology department aims to significantly enhance the efficiency and accuracy of 2D transthoracic echocardiography analysis and reporting. This AI-powered platform is best suited for automating complex measurements, view classifications, heart phase predictions, and report generation, thereby streamlining diagnostic workflows for cardiologists and sonographers.

View Ligence Heart →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Acumen Hypotension Prediction Index (HPI) Feature Software	Ligence Heart
Pricing	Unknown	Contact-for-pricing
Deployment	Unknown	Cloud-based; on-premise; hybrid
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Ligence Heart

Ligence Heart, as a web-based platform that automates complex echocardiography analysis and reporting, offers a direct improvement in workflow efficiency for cardiologists and sonographers. Its integration with existing PACS, EHR, and RIS systems further enhances its ease of use within established clinical environments. Acumen HPI, while integrated into the HemoSphere platform, may require familiarity with that specific system.

Clinical Value

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI offers significant clinical value by providing a predictive warning for hypotensive events up to 15 minutes in advance, with demonstrated reductions in incidence, duration, and severity of intraoperative hypotension. This proactive intervention capability directly impacts patient safety and outcomes in critical care. Ligence Heart enhances diagnostic efficiency and accuracy, which is also valuable, but Acumen HPI's predictive, life-saving potential stands out.

Pricing & Value

Tie

Both tools employ a 'contact vendor' pricing model, with no publicly available information on costs, subscription structures, or specific value propositions. Without any transparent pricing details or comparative ROI data, it is impossible to differentiate between the two on this dimension.

Enterprise Readiness

Ligence Heart

Ligence Heart demonstrates strong enterprise readiness through its flexible deployment options (cloud, on-premise, hybrid) and explicit integration capabilities with common hospital systems like PACS, EHR, and RIS. While Acumen HPI benefits from being an Edwards Lifesciences product, Ligence Heart's stated interoperability and deployment flexibility cater to a broader range of enterprise IT infrastructures.

Innovation

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI presents greater innovation as a 'first-of-its-kind' predictive monitoring tool that uses machine learning to forecast hypotensive events up to 15 minutes before they occur. This proactive, real-time intervention capability for a critical physiological event represents a more novel application of AI in clinical practice compared to Ligence Heart's automation of existing diagnostic workflows.

Support & Docs

Tie

Neither the provided structured facts nor general product descriptions offer specific details regarding support channels, service level agreements, training programs, or documentation for either tool. Without this explicit information, it is not possible to distinguish between them on the basis of support and documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Acumen Hypotension Prediction Index (HPI) Feature Software	Ligence Heart
Name	Acumen Hypotension Prediction Index (HPI) Feature Software	Ligence Heart
Company	Edwards Lifesciences	Ligence
Description	A predictive monitoring tool that uses machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management and improving patient outcomes.	An AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy for cardiologists and sonographers.
Primary Function/Key Focus	Predictive analysis and alerts for impending hypotensive events, aiding in hemodynamic management.	Automated analysis, measurement calculation, and report generation for 2D transthoracic echocardiography.
Specialties	Anesthesiology, Critical Care, Emergency Medicine	Cardiology

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index (HPI) Feature Software and Ligence Heart.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows, and what is their direct clinical impact on patient management?

Acumen HPI integrates into the Edwards Lifesciences HemoSphere advanced monitoring platform, providing a predictive HPI score and alerts to aid proactive hemodynamic management and reduce intraoperative hypotension. Ligence Heart is a web-based platform that automates 2D transthoracic echocardiography analysis and reporting, aiming to enhance diagnostic efficiency and accuracy for cardiologists and sonographers.

Beyond general integration, what specific data points or functionalities are exchanged with the EHR for each tool?

Acumen HPI is integrated into the Edwards Lifesciences HemoSphere advanced monitoring platform, but the specifics of direct data exchange with external EHR systems are not detailed in the provided information. Ligence Heart integrates with existing systems like PACS, EHR, and RIS, facilitating the transfer of echocardiography images (with PHI removed) and automated report generation into these systems.

What evidence or specific metrics are available regarding the accuracy and sensitivity of the predictive analytics or automated measurements provided by each tool?

Acumen HPI uses machine learning and has demonstrated a reduction in the incidence, duration, and severity of intraoperative hypotension, with studies showing high predictive performance (e.g., 89% specificity and 90% sensitivity 10 minutes before an event). Ligence Heart aims to enhance diagnostic efficiency and accuracy through automated echocardiography analysis, with studies indicating non-inferior accuracy compared to cardiologists and reduced variability in measurements.

How do the unique features of each tool specifically cater to the clinical needs of their target specialties?

For Anesthesiology, Critical Care, and Emergency Medicine, Acumen HPI provides a 0-100 HPI score, Smart Alerts, and a Relationship View to proactively manage hemodynamic instability and predict hypotension up to 15 minutes in advance. For Cardiology, Ligence Heart automates comprehensive 2D transthoracic echocardiography analysis, including view classification, measurements, and disease recognition for conditions like heart failure and valvular diseases, streamlining diagnostic workflows.

What is the expected learning curve for physicians and clinical staff to effectively utilize and interpret the insights generated by each tool?

Acumen HPI introduces new parameters like the HPI score and specific screens (Smart Alerts, Smart Trend, Relationship View) within the HemoSphere platform, requiring familiarization with these predictive insights for proactive management. Ligence Heart, as a web-based platform, automates many aspects of echocardiography analysis and reporting, and its interface is designed to be intuitive and user-friendly, potentially simplifying routine tasks and reducing manual tracing.

Do these tools offer features that provide an audit trail or enhance transparency regarding the AI's reasoning behind its predictions or automated analyses?

The provided information for Acumen HPI does not explicitly detail specific audit trail features or mechanisms for understanding the AI's underlying reasoning for its predictions. For Ligence Heart, while it automates measurements and report generation, the available information does not specify features for an audit trail of the AI's decision-making process or transparency into its analytical reasoning, though it notes that medical professionals validate and adjust measurements.